Skip to main content

Find Clinical Trials

Home
Conditions
Potentially Resectable Stage II/IIIa NSCLC

Clinical trial condition

Potentially Resectable Stage II/IIIa NSCLC

Explore clinical trials studying Potentially Resectable Stage II/IIIa NSCLC. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Potentially Resectable Stage II/IIIa NSCLC trial results

Recruiting

Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC

NCT03694236

Conditions: Potentially Resectable Stage II/IIIa NSCLC
Locations: Severance Hospital Seoul, South Korea

View Trial Details